Article
MYC and TP53 Alterations but Not MAPK Pathway Mutations Are Common Oncogenic Mechanisms in Follicular Dendritic Cell Sarcomas.
Archives of pathology & laboratory medicine - 1 Aug 2023
Frigola Gerard, Bühler Marco, Marginet Marta, Enjuanes Anna, Nadeu Ferran, Papaleo Natalia, Salido Marta, Haralambieva Eugenia, Alamo José, Garcia-Bragado Federico, Álvarez Ramiro, Ramos Rafael, Aldecoa Iban, Campo Elías, Colomo Lluis, Balagué Olga
Abstract excerpt
CONTEXT.—: Despite their stromal origin, follicular dendritic cells (FDCs) share many functions with hematopoietic system cells. FDC neoplasms are currently classified by the World Health Organization along with those of a histiocytic nature. However, the molecular alterations driving oncogenesis in FDC sarcomas (FDCSs) are beginning to be unveiled and do not seem to concur with those described in histiocytic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
